SCHEMBL193404

SCHEMBL193404

Nc1ccc(Br)nc1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29892829 1.00
SCHEMBL9903875 0.78
SCHEMBL30051908 0.78
SCHEMBL17255937 0.78 IMPDH2 (0.34)
SCHEMBL474806 0.78
SCHEMBL13191537 0.76
SCHEMBL23629644 0.74
SCHEMBL10197516 0.74
SCHEMBL857644 0.74
SCHEMBL17187244 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115160316-B Orange-red photo-thermal activation delay fluorescent material and synthesis method thereof 苏州大学 2024-03-19 CN claimed
WO-2024026688-A1 ORANGE-RED LIGHT THERMALLY ACTIVATED DELAYED FLUORESCENT MATERIAL AND SYNTHESIS METHOD THEREFOR 苏州大学 2024-02-08 WO claimed
CN-112250718-B Photoelectric dual-response mercury ion probe and preparation method and application thereof 内蒙古工业大学 2023-02-07 CN claimed
CN-115160316-A Orange red photo-thermal activation delayed fluorescent material and synthetic method thereof 苏州大学 2022-10-11 CN claimed
CN-112250718-A Photoelectric dual-response mercury ion probe and preparation method and application thereof 内蒙古工业大学 2021-01-22 CN claimed
CN-102558041-A Method for preparing 3,4-diamino-6-bromopyridine HEFEI COSCIENCE MEDICINE TECHNOLOGY CO LTD 2012-07-11 CN claimed
US-6897231-B2 Indazole derivatives as JNK inhibitors and compositions and methods related thereto SIGNAL PHARMACEUTICALS, INC. (US) 2005-05-24 US claimed
WO-2026107424-A1 N-(4-(IMIDAZO[4,5-B]PYRIDIN-5-YL)-2-PYRIDYL)BENZAMIDE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE BRISTOL-MYERS SQUIBB COMPANY (US) 2026-05-21 WO disclosed
WO-2026107425-A1 5-(PYRIDIN-4-YL)-3H-IMIDAZO[4,5-B]PYRIDINE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE BRISTOL-MYERS SQUIBB COMPANY (US) 2026-05-21 WO disclosed
EP-4741392-A1 1H-PYRAZOLO[4,3-C]PYRIDINE COMPOUND, AND COMPOSITION THEREOF AND USE THEREOF Shenzhen TargetRx Co., Ltd. (CN) 2026-05-13 EP disclosed
EP-4676926-A1 BICYCLIC HETEROARYL COMPOUNDS FOR USE AS GPR35 MODULATORS ThirtyFiveBio Limited (GB) 2026-01-14 EP disclosed
US-20250333399-A1 INHIBITORS OF FIBROBLAST GROWTH FACTOR RECEPTOR KINASES KHORA SPV 1 LLC (US) 2025-10-30 US disclosed
US-20250326748-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING REMIX THERAPEUTICS INC (US) 2025-10-23 US disclosed
CN-1335847-A Sulfonamide compound and pharmaceutical use thereof FUJISAWA PHARMACEUTICAL CO (JP) 2002-02-13 CN disclosed
EP-1136492-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF AS MEDICINES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-09-26 EP disclosed
CN-1268942-A Sulfonamide compounds and medicinal use thereof FUJISAWA PHARMACEUTICAL CO (JP) 2000-10-04 CN disclosed
EP-0995742-A1 SULFONAMIDE COMPOUNDS AND MEDICINAL USE THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-26 EP disclosed
US-4002761-A ANTHELMINTIC AGENTS, FUNGICIDAL AGENTS SMITHKLINE CORPORATION (US) 1977-01-11 US disclosed
US-4000285-A ANTHELMINTICS SMITHKLINE CORPORATION (US) 1976-12-28 US disclosed
US-3961063-A ANTHELMINTICS SMITHKLINE CORPORATION (US) 1976-06-01 US disclosed